280 related articles for article (PubMed ID: 36703729)
61. Effects of phentermine / topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity: A randomized, multicenter, double-blind study.
Bays HE; Hsia DS; Nguyen LT; Peterson CA; Varghese ST
Obes Pillars; 2024 Mar; 9():100099. PubMed ID: 38304225
[TBL] [Abstract][Full Text] [Related]
62. Effects of NWT-03, an egg-protein hydrolysate, on blood pressure in normotensive, high-normotensive and mild-hypertensive men and women: a dose-finding study.
Plat J; Severins N; Morrison S; Mensink RP
Br J Nutr; 2017 Apr; 117(7):942-950. PubMed ID: 28485264
[TBL] [Abstract][Full Text] [Related]
63. Ambulatory blood pressure monitoring and postprandial hypotension in elderly patients with isolated systolic hypertension. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
Grodzicki T; Rajzer M; Fagard R; O'Brien ET; Thijs L; Clement D; Davidson C; Palatini P; Parati G; Kocemba J; Staessen JA
J Hum Hypertens; 1998 Mar; 12(3):161-5. PubMed ID: 9579765
[TBL] [Abstract][Full Text] [Related]
64. Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects.
Zanchi A; Pruijm M; Muller ME; Ghajarzadeh-Wurzner A; Maillard M; Dufour N; Bonny O; Wuerzner G; Burnier M
Front Cardiovasc Med; 2022; 9():854230. PubMed ID: 35391843
[TBL] [Abstract][Full Text] [Related]
65. Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study.
Malacco E; Omboni S; Volpe M; Auteri A; Zanchetti A;
J Hypertens; 2010 Nov; 28(11):2342-50. PubMed ID: 20829713
[TBL] [Abstract][Full Text] [Related]
66. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
Lewin A; Punzi H; Luo X; Stapff M
Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
[TBL] [Abstract][Full Text] [Related]
67. Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial.
Lin J; Wang Q; Zhong D; Zhang J; Yuan T; Wu H; Li B; Li S; Xie X; An D; Deng Y; Xian S; Xiong X; Yao K
Front Pharmacol; 2023; 14():1225529. PubMed ID: 37492087
[No Abstract] [Full Text] [Related]
68. Blood pressure targets for hypertension in people with diabetes mellitus.
Arguedas JA; Leiva V; Wright JM
Cochrane Database Syst Rev; 2013 Oct; (10):CD008277. PubMed ID: 24170669
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
Na SH; Lee HY; Hong Baek S; Jeon HK; Kang JH; Kim YN; Park CG; Ryu JK; Rhee MY; Kim MH; Hong TJ; Choi DJ; Cho SW; Cha DH; Jeon ES; Kim JJ; Shin JH; Park SH; Lee SH; John SH; Shin ES; Kim NH; Lee SY; Kwan J; Jeong MH; Kim SW; Jeong JO; Kim DW; Lee NH; Park WJ; Ahn JC; Won KH; Uk Lee S; Cho JH; Kim SK; Ahn T; Hong S; Yoo SY; Kim SY; Kim BS; Juhn JH; Kim SY; Lee YJ; Oh BH
Clin Ther; 2015 Aug; 37(8):1726-39. PubMed ID: 26164786
[TBL] [Abstract][Full Text] [Related]
70. Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension.
Sellin L; Stegbauer J; Laeis P; Rump LC
J Hypertens; 2005 Nov; 23(11):2083-92. PubMed ID: 16208152
[TBL] [Abstract][Full Text] [Related]
71. The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I).
Williams B; Gosse P; Lowe L; Harper R;
J Hypertens; 2006 Jan; 24(1):193-200. PubMed ID: 16331118
[TBL] [Abstract][Full Text] [Related]
72. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
[TBL] [Abstract][Full Text] [Related]
73. Twenty-four-hour antihypertensive efficacy of felodipine 10 mg extended-release: the Italian inter-university study.
Pannarale G; Puddu PE; Monti F; Irace L; Bentivoglio M; Collauto F; Barsotti A; Corea L; Trevi G; Campa PP; Jacono A
J Cardiovasc Pharmacol; 1996 Feb; 27(2):255-61. PubMed ID: 8720425
[TBL] [Abstract][Full Text] [Related]
74. Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives.
Fogari R; Zoppi A; Mugellini A; Preti P; Corradi L; Lusardi P
Cardiovasc Drugs Ther; 1999 May; 13(3):243-8. PubMed ID: 10439887
[TBL] [Abstract][Full Text] [Related]
75. Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor.
Griebenow R; Pittrow DB; Weidinger G; Mueller E; Mutschler E; Welzel D
Blood Press; 1997 Sep; 6(5):299-306. PubMed ID: 9360001
[TBL] [Abstract][Full Text] [Related]
76. Clinical trial of arotinolol in the treatment of hypertension: dippers vs. non-dippers.
Wu H; Zhang Y; Huang J; Zhang Y; Liu G; Sun N; Yu Z; Zhou Y
Hypertens Res; 2001 Sep; 24(5):605-10. PubMed ID: 11675958
[TBL] [Abstract][Full Text] [Related]
77. Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study.
Hsieh MH; Chan P; Sue YM; Liu JC; Liang TH; Huang TY; Tomlinson B; Chow MS; Kao PF; Chen YJ
Clin Ther; 2003 Nov; 25(11):2797-808. PubMed ID: 14693305
[TBL] [Abstract][Full Text] [Related]
78. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
[TBL] [Abstract][Full Text] [Related]
79. Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.
Neutel J; Kereiakes DJ; Stoakes KA; Maa JF; Shojaee A; Waverczak WF
Drugs Aging; 2011 Jun; 28(6):477-90. PubMed ID: 21639407
[TBL] [Abstract][Full Text] [Related]
80. Quantitative study of circadian variations of ambulatory blood pressure in Chinese healthy, hypertensive, and diabetes subjects.
Zhao ZY; Zhao ZY; Wang YQ; Yan ZH; Cui J; Li YY
Clin Exp Hypertens; 2005; 27(2-3):187-94. PubMed ID: 15835381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
